Glenmark Pharma said on July 10 that its board approved selling 7.84 percent stake in Glenmark Life Sciences through an offer for sale.
“We wish to inform you that the Board of Directors, at its mee… [read more]
Glenmark Pharma said on July 10 that its board approved selling 7.84 percent stake in Glenmark Life Sciences through an offer for sale.
“We wish to inform you that the Board of Directors, at its mee… [read more]
Want to receive all new articles sign up to our Newsletter